Mytos' automated cell culture technology will power manufacturing of dopaminergic neuronal precursor cells for Aspen's investigational cell therapy ANPD001 in Parkinson's disease Mytos, an innovative ...
Aspen Neuroscience, Inc. has advanced its plans for automating production of ANPD001, including a capacity expansion for autologous manufacturing at its San Diego-based GMP facility. ANPD001, an ...